PortfoliosLab logoPortfoliosLab logo
NBY vs. TEL
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

NBY vs. TEL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in NovaBay Pharmaceuticals, Inc. (NBY) and TE Connectivity Ltd. (TEL). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

NBY vs. TEL - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NBY
NovaBay Pharmaceuticals, Inc.
-94.72%1,319.69%-91.58%-89.54%-85.21%-45.97%8.91%-17.17%-79.93%16.67%
TEL
TE Connectivity Ltd.
-7.85%61.60%3.51%24.62%-27.66%35.12%28.95%29.37%-18.87%39.88%

Fundamentals

EPS

NBY:

$0.11

TEL:

$6.93

PE Ratio

NBY:

13.43

TEL:

30.14

PS Ratio

NBY:

15.39

TEL:

3.47

Total Revenue (TTM)

NBY:

$2.83M

TEL:

$17.92B

Gross Profit (TTM)

NBY:

$1.54M

TEL:

$6.27B

EBITDA (TTM)

NBY:

-$7.73M

TEL:

$4.46B

Returns By Period

In the year-to-date period, NBY achieves a -94.72% return, which is significantly lower than TEL's -7.85% return. Over the past 10 years, NBY has underperformed TEL with an annualized return of -57.87%, while TEL has yielded a comparatively higher 14.98% annualized return.


NBY

1D
10.37%
1M
3.47%
YTD
-94.72%
6M
-76.72%
1Y
-22.94%
3Y*
-80.36%
5Y*
-79.31%
10Y*
-57.87%

TEL

1D
5.23%
1M
-9.18%
YTD
-7.85%
6M
-4.18%
1Y
50.03%
3Y*
18.75%
5Y*
11.61%
10Y*
14.98%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


NovaBay Pharmaceuticals, Inc.

TE Connectivity Ltd.

Return for Risk

NBY vs. TEL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NBY
NBY Risk / Return Rank: 5050
Overall Rank
NBY Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
NBY Sortino Ratio Rank: 7474
Sortino Ratio Rank
NBY Omega Ratio Rank: 7575
Omega Ratio Rank
NBY Calmar Ratio Rank: 3333
Calmar Ratio Rank
NBY Martin Ratio Rank: 3333
Martin Ratio Rank

TEL
TEL Risk / Return Rank: 8282
Overall Rank
TEL Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
TEL Sortino Ratio Rank: 7979
Sortino Ratio Rank
TEL Omega Ratio Rank: 8282
Omega Ratio Rank
TEL Calmar Ratio Rank: 8181
Calmar Ratio Rank
TEL Martin Ratio Rank: 8383
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NBY vs. TEL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for NovaBay Pharmaceuticals, Inc. (NBY) and TE Connectivity Ltd. (TEL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NBYTELDifference

Sharpe ratio

Return per unit of total volatility

-0.10

1.47

-1.56

Sortino ratio

Return per unit of downside risk

1.81

1.99

-0.17

Omega ratio

Gain probability vs. loss probability

1.25

1.30

-0.05

Calmar ratio

Return relative to maximum drawdown

-0.26

2.36

-2.62

Martin ratio

Return relative to average drawdown

-0.50

6.86

-7.36

NBY vs. TEL - Sharpe Ratio Comparison

The current NBY Sharpe Ratio is -0.10, which is lower than the TEL Sharpe Ratio of 1.47. The chart below compares the historical Sharpe Ratios of NBY and TEL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


NBYTELDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.10

1.47

-1.56

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.57

0.43

-1.00

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.17

0.54

-0.71

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.19

0.39

-0.58

Correlation

The correlation between NBY and TEL is 0.07, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

NBY vs. TEL - Dividend Comparison

NBY's dividend yield for the trailing twelve months is around 268.46%, more than TEL's 1.36% yield.


TTM20252024202320222021202020192018201720162015
NBY
NovaBay Pharmaceuticals, Inc.
268.46%14.18%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TEL
TE Connectivity Ltd.
1.36%1.22%1.78%1.66%1.90%1.23%1.57%1.90%2.27%1.65%2.08%1.98%

Drawdowns

NBY vs. TEL - Drawdown Comparison

The maximum NBY drawdown since its inception was -100.00%, which is greater than TEL's maximum drawdown of -81.07%. Use the drawdown chart below to compare losses from any high point for NBY and TEL.


Loading graphics...

Drawdown Indicators


NBYTELDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-81.07%

-18.93%

Max Drawdown (1Y)

Largest decline over 1 year

-98.79%

-20.85%

-77.94%

Max Drawdown (5Y)

Largest decline over 5 years

-99.97%

-34.26%

-65.71%

Max Drawdown (10Y)

Largest decline over 10 years

-99.99%

-47.71%

-52.28%

Current Drawdown

Current decline from peak

-100.00%

-15.52%

-84.48%

Average Drawdown

Average peak-to-trough decline

-82.50%

-13.63%

-68.87%

Ulcer Index

Depth and duration of drawdowns from previous peaks

51.59%

7.17%

+44.42%

Volatility

NBY vs. TEL - Volatility Comparison

NovaBay Pharmaceuticals, Inc. (NBY) has a higher volatility of 37.42% compared to TE Connectivity Ltd. (TEL) at 11.33%. This indicates that NBY's price experiences larger fluctuations and is considered to be riskier than TEL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


NBYTELDifference

Volatility (1M)

Calculated over the trailing 1-month period

37.42%

11.33%

+26.09%

Volatility (6M)

Calculated over the trailing 6-month period

187.53%

24.94%

+162.59%

Volatility (1Y)

Calculated over the trailing 1-year period

241.32%

34.25%

+207.07%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

139.53%

27.27%

+112.26%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

333.73%

27.90%

+305.83%

Financials

NBY vs. TEL - Financials Comparison

This section allows you to compare key financial metrics between NovaBay Pharmaceuticals, Inc. and TE Connectivity Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
521.00K
4.67B
(NBY) Total Revenue
(TEL) Total Revenue
Values in USD except per share items